Skip to content

Welcome to Discover Pharma! Today is : October 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

regenerative medicine

  • Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Oral BioLife appoints Greg Ambra as CEO and strengthens leadership team

    Oral BioLife, a regenerative technology company developing non-invasive therapies to [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    DEBRA Research and Queen Mary University of London partner to advance drug development for rare skin disorder

    DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    PL BioScience opens new headquarters to support growing demand for HPL production

    1,200 m² Aachen facility will enable largest global HPL output [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Medical devices

    TISSIUM secures FDA De Novo nod for sutureless nerve repair system

    TISSIUM has received De Novo authorization from the US Food [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    Rare bone disorder: Novadip reports long-term success for pediatric patients treated under compassionate use programme

    Novadip Biosciences and Cliniques universitaires Saint-Luc have reported successful long-term [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory

    Nanoscope Therapeutics begins FDA submission for gene-agnostic therapy to treat retinitis pigmentosa

    Nanoscope Therapeutics has initiated a rolling submission for its Biologics [...]

    May 5, 2026
  • Advanced Therapies,Manufacturing & Supply Chain

    Celularity and Fountain Life partner to deliver stem cell therapies under new Florida Law

    Celularity and Fountain Life have formed a strategic partnership to [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    Novadip’s autologous cell therapy NVD003 receives RMAT designation for rare pediatric bone disorder

    FDA recognises regenerative approach for congenital pseudarthrosis of the tibia [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Opinion & Events

    Cellino and Karis Bio join forces to deliver personalized cell therapy in Asia-Pacific

    Cellino and Karis Bio have announced a strategic partnership to [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory

    Genetically engineered pig liver enters first-in-human trial for patients with no transplant option

    OrganOx and eGenesis launch human trial of a genetically modified [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kindeva wins $226 million contract for nerve agent antidote autoinjectors
    Categories: Manufacturing & Supply Chain
  • Nabsys launches RepX for repeat expansion analysis
    Categories: Genomics and sequencing
  • NICE recommends maralixibat for Alagille syndrome itching
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top